FIBROBIOLOGICS INC FBLG

US Healthcare Pharmaceutical Preparations
$0.88
-3.3%
52w: $0.73 – $14.92

Latest 13F among current holders filed 32 days ago (Jun 3, 2026)

Price — last 12 months

research preview data
0.737.8314.92
Jun 20, 2025 Jul 2, 2026
Institutional holders
17
+16 QoQ
13F value
$291K
+4157928.6% QoQ
Smart-money holders
0
signal tier ≥ 2
New smart buyers
0
Q1 2026

Institutional value by quarter

$7
Q2 2025
$291K
Q1 2026

Number of holders

1
Q2 2025
17
Q1 2026

Who owns FBLG?

Q1 2026 filings
FundTypeSharesValue% of fundChange
VANGUARD CAPITAL MANAGEMENT LLC Diversified mechanical67.7K$89K0.0%
Fund Evaluation Group, LLC Wealth advisor51.8K$68K0.0%New
GEODE CAPITAL MANAGEMENT, LLC Index provider29.6K$39K0.0%New
BlackRock, Inc. Index provider24.6K$33K0.0%New
Cascade Financial Partners, LLC Wealth advisor16.4K$22K0.0%New
RENAISSANCE TECHNOLOGIES LLC Quant stat arb16.0K$21K0.0%New
VANGUARD FIDUCIARY TRUST CO Diversified mechanical6.4K$8K0.0%
UBS Group AG Bank broker5.7K$8K0.0%New
NewEdge Advisors, LLC Diversified mechanical845$1K0.0%New
Vanguard Global Advisers, LLC Diversified mechanical536$7080.0%
Tower Research Capital LLC (TRC) Market maker460$6070.0%New
ISLAY CAPITAL MANAGEMENT, LLC Wealth advisor169$2230.0%New
OSAIC HOLDINGS, INC. Wealth advisor154$2030.0%New
BNP PARIBAS FINANCIAL MARKETS Bank broker66$870.0%New
Allworth Financial LP Wealth advisor13$180.0%New
WELLS FARGO & COMPANY/MN Bank broker10$130.0%New
ROYAL BANK OF CANADA Bank broker186$00.0%New

Exits are not a bearish signal: our backtest shows stocks specialists exit keep outperforming for 3+ quarters — selling usually means profit-taking, not a forecast.